These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34108879)

  • 1. Astragaloside IV Attenuates the Myocardial Injury Caused by Adriamycin by Inhibiting Autophagy.
    Luo LF; Qin LY; Wang JX; Guan P; Wang N; Ji ES
    Front Pharmacol; 2021; 12():669782. PubMed ID: 34108879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Astragaloside IV Against Adriamycin-Induced Renal Damage in Rats
    Qin LY; Guan P; Wang JX; Chen Y; Zhao YS; Yang SC; Guo YJ; Wang N; Ji ES
    Front Pharmacol; 2022; 13():812594. PubMed ID: 35370757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling.
    Luo LF; Guan P; Qin LY; Wang JX; Wang N; Ji ES
    Mol Cell Biochem; 2021 Jul; 476(7):2603-2611. PubMed ID: 33656642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of Combined Intervention of Electroacupuncture and Astragaloside IV on Myocardial Hypertrophy and TGF-β 1/Smad Signaling in Rats with Myocardial Fibrosis].
    Li JS; Zhu XY; Lu ML; Gao JH; Wang HX; Yu XC
    Zhen Ci Yan Jiu; 2017 Dec; 42(6):477-81. PubMed ID: 29318851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin Attenuates Adriamycin-Induced Cardiomyocyte Apoptosis via the PI3K/AKT/mTOR Pathway.
    Yu W; Sun H; Zha W; Cui W; Xu L; Min Q; Wu J
    Evid Based Complement Alternat Med; 2017; 2017():2590676. PubMed ID: 28684964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV attenuates sunitinib-associated cardiotoxicity by inhibiting COUP-TFII.
    Qin W; Li S; Cheng Z; Xue W; Tian M; Mou F; Guo H; Shao S; Liu B
    Heliyon; 2024 Feb; 10(3):e24779. PubMed ID: 38314260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single, Acute Astragaloside IV Therapy Protects Cardiomyocyte Through Attenuating Superoxide Anion-Mediated Accumulation of Autophagosomes in Myocardial Ischemia-Reperfusion Injury.
    Huang KY; Yu YW; Liu S; Zhou YY; Wang JS; Peng YP; Ji KT; Xue YJ
    Front Pharmacol; 2021; 12():642925. PubMed ID: 34349641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of Astragalus injection on cardiomyocyte apoptosis, endoplasmic reticulum stress and expression of connexin in cardiomyopathy rats induced by adriamycin].
    He ZH; Shao LQ; Xuan LY; Wang CG; Wei CX; Wang Y; Zhao M
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Feb; 34(2):159-163. PubMed ID: 29926682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astragaloside IV attenuates injury caused by myocardial ischemia/reperfusion in rats via regulation of toll-like receptor 4/nuclear factor-κB signaling pathway.
    Lu M; Tang F; Zhang J; Luan A; Mei M; Xu C; Zhang S; Wang H; Maslov LN
    Phytother Res; 2015 Apr; 29(4):599-606. PubMed ID: 25604645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astragaloside IV attenuates apoptosis of hypertrophic cardiomyocyte through inhibiting oxidative stress and calpain-1 activation.
    Mei M; Tang F; Lu M; He X; Wang H; Hou X; Hu J; Xu C; Han R
    Environ Toxicol Pharmacol; 2015 Nov; 40(3):764-73. PubMed ID: 26433482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astragaloside IV mitigates hypoxia-induced cardiac hypertrophy through calpain-1-mediated mTOR activation.
    Zhang J; Lu M; Li C; Yan B; Xu F; Wang H; Zhang Y; Yang Y
    Phytomedicine; 2024 Mar; 125():155250. PubMed ID: 38295664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway.
    Nie P; Meng F; Zhang J; Wei X; Shen C
    Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of astragaloside IV against rat myocardial cell apoptosis induced by oxidative stress via mitochondrial ATP-sensitive potassium channels.
    Guan FY; Yang SJ; Liu J; Yang SR
    Mol Med Rep; 2015 Jul; 12(1):371-6. PubMed ID: 25739067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragaloside IV inhibits isoprenaline‑induced cardiac fibrosis by targeting the reactive oxygen species/mitogen‑activated protein kinase signaling axis.
    Dai H; Jia G; Lu M; Liang C; Wang Y; Wang H
    Mol Med Rep; 2017 Apr; 15(4):1765-1770. PubMed ID: 28260010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astragaloside IV protects LO2 cells from oxidative damage caused by radiation-induced bystander effect through Akt/Nrf2 pathway.
    Wan D; Zhu Z; Zhou J; Deng Z; Lei P; Liu Q; Sun X; Huang B
    Toxicol Res (Camb); 2023 Aug; 12(4):635-647. PubMed ID: 37663802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compatibility of Tanshinone IIA and Astragaloside IV in attenuating hypoxia-induced cardiomyocytes injury.
    Wang D; Liu Y; Zhong G; Wang Y; Zhang T; Zhao Z; Yan X; Liu Q
    J Ethnopharmacol; 2017 May; 204():67-76. PubMed ID: 28389356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV improves the isoproterenol-induced vascular dysfunction via attenuating eNOS uncoupling-mediated oxidative stress and inhibiting ROS-NF-κB pathways.
    Xu C; Tang F; Lu M; Yang J; Han R; Mei M; Hu J; Zhou M; Wang H
    Int Immunopharmacol; 2016 Apr; 33():119-27. PubMed ID: 26903414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astragaloside IV-targeting miRNA-1 attenuates lipopolysaccharide-induced cardiac dysfunction in rats through inhibition of apoptosis and autophagy.
    Wang Q; Yang X; Song Y; Sun X; Li W; Zhang L; Hu X; Wang H; Zhao N; Zhuang R; Xie X; Tang F; Wang H
    Life Sci; 2021 Jun; 275():119414. PubMed ID: 33774032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium Sensing Receptor-Related Pathway Contributes to Cardiac Injury and the Mechanism of Astragaloside IV on Cardioprotection.
    Lu M; Leng B; He X; Zhang Z; Wang H; Tang F
    Front Pharmacol; 2018; 9():1163. PubMed ID: 30364197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astragaloside IV enhances the sensitivity of breast cancer stem cells to paclitaxel by inhibiting stemness.
    Huang P; Li H; Ren L; Xie H; Chen L; Liang Y; Hu Y; Selistre-de-Araujo HS; Boussios S; Jhawar SR; Cui R; Zuo Q; Chen Q
    Transl Cancer Res; 2023 Dec; 12(12):3703-3717. PubMed ID: 38193000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.